Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma.

There was a similar trend that did not reach statistical significance in a recent large, randomized multicenter study. 6 , 8 The effectiveness of mTOR inhibitor immunotherapy in preventing and treating SCC and other malignancies in transplant patient may not be surprising given mTOR activates cellular growth.

also in 111,027 other papers